RGR Stock Analysis: Sturm Ruger | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 624m USD | 12M Return: 11.3% | US8641591081 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.57M
EPS Trend: -94.6%
Qual. Beats: 0
Rev. Trend: 37.7%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sturm, Ruger & Company, Inc. is a U.S.-based firearms manufacturer founded in 1949 and headquartered in Southport, Connecticut. Operating in two segments-Firearms and Castings-the company designs, manufactures, and sells a broad range of firearms under the Ruger brand, including rifles, pistols, revolvers, and shotguns, as well as lever-action rifles under the Marlin name. Beyond firearms, Ruger produces steel investment castings and metal injection molding (MIM) parts. The company distributes its firearm products to the commercial sporting market through independent wholesale distributors, while also exporting to foreign law enforcement agencies and governments, and selling castings directly or via manufacturers representatives.
The firearms industry experiences demand fluctuations tied to consumer sentiment, regulatory developments, and election cycles, often resulting in higher sales volumes during periods of political uncertainty. Rugers diversified revenue streams-including its castings and MIM components business-help offset the cyclical nature of the commercial firearms market and provide entry into non-sporting industrial end markets such as aerospace and medical equipment.
- Commercial firearms demand softens as distributor inventory normalizes
- Marlin lever-action rifle ramp drives product mix and pricing gains
- Federal and state firearms regulation shifts impact consumer purchasing sentiment
- Quarterly dividend and special distributions reward shareholders amid margin pressure
| Net Income: 12.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 1.42 > 1.0 |
| NWC/Revenue: 29.02% < 20% (prev 31.57%; Δ -2.55% < -1%) |
| CFO/TA 0.17 > 3% & CFO 62.1m > Net Income 12.2m |
| Net Debt (-115.0m) to EBITDA (32.5m): -3.54 < 3 |
| Current Ratio: 3.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.3m) vs 12m ago -0.60% < -2% |
| Gross Margin: 18.70% > 18% (prev 16.95%; Δ 1.75% > 0.5%) |
| Asset Turnover: 161.7% > 50% (prev 153.4%; Δ 8.30% > 0%) |
| Interest Coverage Ratio: 82.52 > 6 (EBIT TTM 8.34m / Interest Expense TTM 101k) |
| A: 0.46 (Total Current Assets 239.0m - Total Current Liabilities 71.4m) / Total Assets 364.3m |
| B: 1.17 (Retained Earnings 426.1m / Total Assets 364.3m) |
| C: 0.02 (EBIT TTM 8.34m / Avg Total Assets 356.9m) |
| D: 3.89 (Book Value of Equity 289.8m / Total Liabilities 74.5m) |
| Altman-Z'' = 11.07 = AAA |
| DSRI: 1.16 (Receivables 77.1m/61.8m, Revenue 577.2m/536.3m) |
| GMI: 0.91 (GM 16.95% / 18.70%) |
| AQI: 0.85 (AQ_t 0.13 / AQ_t-1 0.16) |
| SGI: 1.08 (Revenue 577.2m / 536.3m) |
| TATA: -0.14 (NI 12.2m - CFO 62.1m) / TA 364.3m) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of August 26, 2026, the stock is trading at USD 38.46 with a total of 114,945 shares traded. Over the past week, the price has changed by +2.72%, over one month by +1.17%, over three months by -3.81% and over the past year by +11.25%.
Current recommended Stop Loss: 36.10 (which is 6.1% or 2.5 ATR below the current price).
Sturm Ruger has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy RGR.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 43 | 11.8% |
P/E Trailing = 52.7973
P/E Forward = 8.6133
P/S = 1.0815
P/B = 2.1542
Revenue TTM = 577.2m USD
EBIT TTM = 8.34m USD
EBITDA TTM = 32.5m USD
Long Term Debt = 1.01m USD (estimated: total debt 1.49m - short term 481k)
Short Term Debt = 481k USD (from shortTermDebt, last quarter)
Debt = 2.50m USD (from shortLongTermDebtTotal, last quarter) + Leases 1.01m
Net Debt = -115.0m USD (calculated: Debt 2.50m - CCE 117.5m)
Enterprise Value = 509.3m USD (624.3m + Debt 2.50m - CCE 117.5m)
Interest Coverage Ratio = 82.52 (Ebit TTM 8.34m / Interest Expense TTM 101k)
EV/FCF = 11.34x (Enterprise Value 509.3m / FCF TTM 44.9m)
FCF Yield = 8.82% (FCF TTM 44.9m / Enterprise Value 509.3m)
FCF Margin = 7.78% (FCF TTM 44.9m / Revenue TTM 577.2m)
Net Margin = 2.11% (Net Income TTM 12.2m / Revenue TTM 577.2m)
Gross Margin = 18.70% ((Revenue TTM 577.2m - Cost of Revenue TTM 469.3m) / Revenue TTM)
Gross Margin QoQ = 21.35% (prev 19.86%)
Tobins Q-Ratio = 1.40 (Enterprise Value 509.3m / Total Assets 364.3m)
Interest Expense / Debt = 4.04% (Interest Expense 101k / Debt 2.50m)
Taxrate = 21.56% (1.92m / 8.90m)
NOPAT = 6.54m (EBIT 8.34m * (1 - 21.56%))
Current Ratio = 3.35 (Total Current Assets 239.0m / Total Current Liabilities 71.4m)
Debt / Equity = 0.01 (Debt 2.50m / totalStockholderEquity, last quarter 289.8m)
Debt / EBITDA = -3.54 (Net Debt -115.0m / EBITDA 32.5m)
Debt / FCF = -2.56 (Net Debt -115.0m / FCF TTM 44.9m)
Total Stockholder Equity = 284.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.41% (Net Income 12.2m / Total Assets 364.3m)
RoE = 4.29% (Net Income TTM 12.2m / Total Stockholder Equity 284.1m)
RoCE = 2.92% (EBIT 8.34m / Capital Employed (Equity 284.1m + L.T.Debt 1.01m))
RoIC = 2.47% (NOPAT 6.54m / Invested Capital 264.5m)
WACC = 6.80% (E(624.3m)/V(626.8m) * Re(6.81%) + D(2.50m)/V(626.8m) * Rd(4.04%) * (1-Tc(0.22)))
Discount Rate = 6.81% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.02 | Cagr: -3.52%
[DCF] Terminal Value 77.97% ; FCFF base≈42.2m ; Y1≈48.4m ; Y5≈71.2m
[DCF] Fair Price = 74.27 (EV 1.07b - Net Debt -115.0m = Equity 1.19b / Shares 16.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -94.64 | EPS CAGR: -29.54% | SUE: 0.79 | # QB: 0
Revenue Correlation: 37.66 | Revenue CAGR: 1.27% | SUE: 2.68 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.37 | Chg30d=-5.13% | Revisions=-25% | Analysts=2
EPS current Year (2026-12-31): EPS=1.59 | Chg30d=-6.18% | Revisions=+0% | GrowthEPS=+89.9% | GrowthRev=+6.9%
EPS next Year (2027-12-31): EPS=2.02 | Chg30d=+2.27% | Revisions=+0% | GrowthEPS=+27.0% | GrowthRev=+1.6%
[Analyst] Revisions Ratio: -25% (up=0, down=1)